| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.852 | 0.003 | 0.853 | Vasodilator, coronary | 0.853 0.003 DBMET01615 0.68 0.005 DBMET01616 0.334 0.064 DBMET01617 | DBMET01615 | |
| 0.776 | 0.004 | 0.776 | Cardiotonic | 0.761 0.005 DBMET01615 0.754 0.005 DBMET01616 | ||
| 0.74 | 0.004 | 0.74 | P-glycoprotein inhibitor | 0.726 0.004 DBMET01615 0.729 0.004 DBMET01616 0.164 0.096 DBMET01617 | ||
| 0.644 | 0.001 | 0.654 | Calcium antagonist | 0.654 0.001 DBMET01615 0.518 0.002 DBMET01616 0.141 0.026 DBMET01617 | DBMET01615 | |
| 0.614 | 0.012 | 0.62 | Spasmolytic | 0.62 0.011 DBMET01615 0.594 0.014 DBMET01616 0.218 0.107 DBMET01617 | DBMET01615 | |
| 0.584 | 0.004 | 0.605 | Calcium channel blocker | 0.605 0.003 DBMET01615 0.446 0.004 DBMET01616 | DBMET01615 | |
| 0.588 | 0.017 | 0.588 | Vasodilator, peripheral | 0.578 0.018 DBMET01615 0.371 0.065 DBMET01616 0.236 0.139 DBMET01617 | ||
| 0.557 | 0.019 | 0.564 | Immunosuppressant | 0.544 0.022 DBMET01615 0.564 0.018 DBMET01616 | DBMET01616 | |
| 0.532 | 0.01 | 0.532 | Vasodilator | 0.516 0.011 DBMET01615 0.519 0.01 DBMET01616 | ||
| 0.536 | 0.022 | 0.536 | 5 Hydroxytryptamine release stimulant | 0.533 0.022 DBMET01615 0.377 0.05 DBMET01616 0.497 0.028 DBMET01617 | ||
| 0.411 | 0.015 | 0.522 | Anesthetic general | 0.408 0.015 DBMET01615 0.522 0.007 DBMET01616 0.229 0.06 DBMET01617 | DBMET01616 | |
| 0.398 | 0.007 | 0.442 | Nav1.2 sodium channel blocker | 0.428 0.006 DBMET01615 0.442 0.005 DBMET01616 | DBMET01616 | |
| 0.354 | 0.003 | 0.367 | Calcium channel L-type blocker | 0.367 0.003 DBMET01615 0.251 0.004 DBMET01616 | DBMET01615 | |
| 0.338 | 0.005 | 0.352 | Calcium channel (voltage-sensitive) blocker | 0.352 0.005 DBMET01615 0.244 0.011 DBMET01616 | DBMET01615 | |
| 0.337 | 0.011 | 0.337 | Antiadrenergic | 0.322 0.012 DBMET01615 0.106 0.052 DBMET01616 | ||
| 0.334 | 0.011 | 0.334 | Adrenaline antagonist | 0.319 0.012 DBMET01615 0.102 0.052 DBMET01616 | ||
| 0.309 | 0.012 | 0.325 | Anesthetic local | 0.325 0.01 DBMET01615 0.293 0.013 DBMET01616 0.115 0.071 DBMET01617 | DBMET01615 | |
| 0.347 | 0.052 | 0.393 | Calcium channel activator | 0.344 0.054 DBMET01615 0.29 0.102 DBMET01616 0.393 0.027 DBMET01617 | DBMET01617 | |
| 0.293 | 0.009 | 0.312 | Nav1.1 sodium channel blocker | 0.291 0.009 DBMET01615 0.312 0.008 DBMET01616 | DBMET01616 | |
| 0.287 | 0.01 | 0.302 | Nav1.3 sodium channel blocker | 0.302 0.009 DBMET01615 0.273 0.011 DBMET01616 | DBMET01615 | |
| 0.276 | 0.007 | 0.401 | Nav1.6 sodium channel blocker | 0.29 0.006 DBMET01615 0.401 0.004 DBMET01616 | DBMET01616 | |
| 0.33 | 0.072 | 0.378 | Antithrombotic | 0.319 0.077 DBMET01615 0.378 0.055 DBMET01616 0.288 0.096 DBMET01617 | DBMET01616 | |
| 0.29 | 0.054 | 0.64 | Superoxide dismutase inhibitor | 0.294 0.053 DBMET01615 0.468 0.016 DBMET01616 0.64 0.005 DBMET01617 | DBMET01617 | |
| 0.216 | 0.016 | 0.216 | Bronchodilator | 0.202 0.018 DBMET01615 0.162 0.028 DBMET01617 | ||
| 0.209 | 0.01 | 0.209 | Vanilloid 1 agonist | 0.201 0.012 DBMET01615 0.196 0.013 DBMET01616 0.171 0.023 DBMET01617 | ||
| 0.192 | 0.004 | 0.199 | Potassium channel Kv1.3 blocker | 0.199 0.004 DBMET01615 0.161 0.004 DBMET01616 0.051 0.028 DBMET01617 | DBMET01615 | |
| 0.211 | 0.026 | 0.211 | Alpha adrenoreceptor antagonist | 0.21 0.026 DBMET01615 0.086 0.066 DBMET01616 | ||
| 0.261 | 0.085 | 0.261 | Ca(v)3.3 blocker | 0.259 0.087 DBMET01615 0.217 0.158 DBMET01616 0.22 0.152 DBMET01617 | ||
| 0.187 | 0.015 | 0.193 | Nav1.5 sodium channel blocker | 0.193 0.014 DBMET01615 0.178 0.017 DBMET01616 | DBMET01615 | |
| 0.184 | 0.014 | 0.184 | Multidrug resistance-associated protein 1 inhibitor | 0.182 0.014 DBMET01615 0.174 0.017 DBMET01616 0.099 0.08 DBMET01617 | ||
| 0.182 | 0.014 | 0.182 | Sphingosine 1-phosphate receptor 2 antagonist | 0.175 0.018 DBMET01615 0.129 0.075 DBMET01616 0.124 0.087 DBMET01617 | ||
| 0.227 | 0.069 | 0.241 | Peptidyltransferase inhibitor | 0.216 0.08 DBMET01615 0.241 0.057 DBMET01616 | DBMET01616 | |
| 0.251 | 0.095 | 0.251 | Insulysin inhibitor | 0.239 0.107 DBMET01615 0.239 0.107 DBMET01616 0.25 0.096 DBMET01617 | ||
| 0.163 | 0.007 | 0.367 | Glutamate release inhibitor | 0.165 0.007 DBMET01615 0.367 0.003 DBMET01616 0.087 0.068 DBMET01617 | DBMET01616 | |
| 0.178 | 0.023 | 0.183 | Calcium channel N-type blocker | 0.183 0.021 DBMET01615 0.141 0.043 DBMET01616 | DBMET01615 | |
| 0.193 | 0.039 | 0.194 | Neurotensin receptor agonist | 0.187 0.043 DBMET01615 0.194 0.038 DBMET01616 0.167 0.067 DBMET01617 | DBMET01616 | |
| 0.158 | 0.008 | 0.169 | Histamine H2 receptor antagonist | 0.169 0.007 DBMET01615 0.137 0.013 DBMET01616 | DBMET01615 | |
| 0.149 | 0.004 | 0.156 | Estrogen-related receptor beta agonist | 0.156 0.004 DBMET01615 0.119 0.01 DBMET01616 0.117 0.011 DBMET01617 | DBMET01615 | |
| 0.26 | 0.12 | 0.395 | Transcription factor NF kappa B inhibitor | 0.252 0.126 DBMET01615 0.236 0.137 DBMET01616 0.395 0.065 DBMET01617 | DBMET01617 | |
| 0.142 | 0.008 | 0.142 | Calcium channel T-type blocker | 0.142 0.008 DBMET01615 0.111 0.013 DBMET01616 | ||
| 0.183 | 0.05 | 0.317 | Melanin inhibitor | 0.18 0.051 DBMET01615 0.191 0.045 DBMET01616 0.317 0.02 DBMET01617 | DBMET01617 | |
| 0.15 | 0.021 | 0.157 | Electron transport complex I inhibitor | 0.147 0.022 DBMET01615 0.119 0.049 DBMET01616 0.157 0.017 DBMET01617 | DBMET01617 | |
| 0.23 | 0.104 | 0.428 | 5 Hydroxytryptamine uptake stimulant | 0.213 0.128 DBMET01615 0.263 0.069 DBMET01616 0.428 0.01 DBMET01617 | DBMET01617 | |
| 0.137 | 0.013 | 0.137 | Vanilloid agonist | 0.129 0.015 DBMET01615 0.123 0.017 DBMET01616 0.085 0.058 DBMET01617 | ||
| 0.122 | 0.004 | 0.123 | Melatonin agonist | 0.123 0.004 DBMET01615 0.032 0.024 DBMET01616 0.031 0.026 DBMET01617 | DBMET01615 | |
| 0.156 | 0.045 | 0.167 | Farnesoid X receptor antagonist | 0.155 0.047 DBMET01615 0.167 0.036 DBMET01616 | DBMET01616 | |
| 0.157 | 0.051 | 0.158 | Adenylate cyclase stimulant | 0.148 0.067 DBMET01615 0.147 0.068 DBMET01616 0.158 0.05 DBMET01617 | DBMET01617 | |
| 0.14 | 0.038 | 0.201 | TRPA1 agonist | 0.148 0.033 DBMET01615 0.168 0.02 DBMET01616 0.201 0.01 DBMET01617 | DBMET01617 | |
| 0.214 | 0.112 | 0.342 | Tyrosine 3 hydroxylase inhibitor | 0.199 0.137 DBMET01615 0.248 0.07 DBMET01616 0.342 0.018 DBMET01617 | DBMET01617 | |
| 0.123 | 0.024 | 0.157 | Ornithine decarboxylase inhibitor | 0.113 0.032 DBMET01615 0.157 0.009 DBMET01616 0.11 0.034 DBMET01617 | DBMET01616 | |
| 0.138 | 0.043 | 0.189 | Falcipain 3 inhibitor | 0.138 0.043 DBMET01615 0.094 0.076 DBMET01616 0.189 0.021 DBMET01617 | DBMET01617 | |
| 0.16 | 0.066 | 0.16 | Acetylcholine M1 receptor antagonist | 0.154 0.07 DBMET01615 0.154 0.071 DBMET01616 | ||
| 0.095 | 0.004 | 0.095 | Melatonin 1 agonist | 0.094 0.004 DBMET01615 0.037 0.018 DBMET01616 0.031 0.027 DBMET01617 | ||
| 0.127 | 0.037 | 0.145 | Sphingomyelinase inhibitor | 0.136 0.031 DBMET01615 0.114 0.046 DBMET01616 0.145 0.027 DBMET01617 | DBMET01617 | |
| 0.171 | 0.082 | 0.202 | MAP kinase kinase 5 inhibitor | 0.177 0.069 DBMET01615 0.202 0.031 DBMET01616 | DBMET01616 | |
| 0.199 | 0.12 | 0.246 | Neuropeptide Y2 antagonist | 0.202 0.115 DBMET01615 0.246 0.06 DBMET01616 | DBMET01616 | |
| 0.086 | 0.008 | 0.086 | Vanilloid 2 antagonist | 0.083 0.009 DBMET01615 0.064 0.019 DBMET01616 0.064 0.018 DBMET01617 | ||
| 0.116 | 0.039 | 0.182 | Protein kinase C delta inhibitor | 0.11 0.044 DBMET01615 0.182 0.011 DBMET01616 | DBMET01616 | |
| 0.122 | 0.046 | 0.139 | Acetylcholine release stimulant | 0.125 0.041 DBMET01615 0.139 0.024 DBMET01617 | DBMET01617 | |
| 0.117 | 0.041 | 0.15 | Breast cancer-resistant protein inhibitor | 0.121 0.038 DBMET01615 0.15 0.024 DBMET01617 | DBMET01617 | |
| 0.133 | 0.06 | 0.177 | Cathepsin H inhibitor | 0.135 0.059 DBMET01615 0.168 0.035 DBMET01616 0.177 0.03 DBMET01617 | DBMET01617 | |
| 0.184 | 0.119 | 0.257 | Nitric-oxide synthase stimulant | 0.177 0.135 DBMET01615 0.257 0.028 DBMET01617 | DBMET01617 | |
| 0.181 | 0.116 | 0.553 | Aldehyde oxidase inhibitor | 0.179 0.117 DBMET01615 0.446 0.04 DBMET01616 0.553 0.025 DBMET01617 | DBMET01617 | |
| 0.223 | 0.158 | 0.224 | Sodium/bile acid cotransporter inhibitor | 0.224 0.157 DBMET01615 0.21 0.175 DBMET01617 | DBMET01615 | |
| 0.179 | 0.118 | 0.2 | Platelet antagonist | 0.175 0.121 DBMET01615 0.2 0.101 DBMET01616 | DBMET01616 | |
| 0.06 | 0.008 | 0.062 | Melatonin 2 agonist | 0.062 0.007 DBMET01615 0.033 0.023 DBMET01617 | DBMET01615 | |
| 0.137 | 0.086 | 0.143 | Neuropeptide Y1 antagonist | 0.143 0.076 DBMET01615 | DBMET01615 | |
| 0.124 | 0.073 | 0.168 | Cyclooxygenase 3 inhibitor | 0.132 0.064 DBMET01615 0.143 0.055 DBMET01616 0.168 0.035 DBMET01617 | DBMET01617 | |
| 0.152 | 0.102 | 0.215 | Phospholipase C inhibitor | 0.148 0.109 DBMET01615 0.215 0.036 DBMET01616 0.145 0.117 DBMET01617 | DBMET01616 | |
| 0.124 | 0.074 | 0.193 | Toll-Like receptor 2 antagonist | 0.116 0.083 DBMET01615 0.152 0.052 DBMET01616 0.193 0.027 DBMET01617 | DBMET01617 | |
| 0.182 | 0.132 | 0.274 | Calpain inhibitor | 0.185 0.129 DBMET01615 0.274 0.045 DBMET01617 | DBMET01617 | |
| 0.078 | 0.029 | 0.081 | Beta adrenoreceptor antagonist | 0.081 0.026 DBMET01615 0.062 0.052 DBMET01617 | DBMET01615 | |
| 0.17 | 0.124 | 0.231 | Free radical scavenger | 0.169 0.125 DBMET01615 0.231 0.077 DBMET01617 | DBMET01617 | |
| 0.092 | 0.047 | 0.092 | Alpha 1 adrenoreceptor antagonist | 0.092 0.046 DBMET01615 | ||
| 0.068 | 0.028 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 DBMET01615 0.06 0.035 DBMET01617 | DBMET01615 | |
| 0.084 | 0.043 | 0.084 | Alpha 1b adrenoreceptor antagonist | 0.082 0.044 DBMET01615 | ||
| 0.12 | 0.08 | 0.274 | Tubulin antagonist | 0.126 0.075 DBMET01615 0.114 0.086 DBMET01616 0.274 0.022 DBMET01617 | DBMET01617 | |
| 0.085 | 0.046 | 0.085 | Ca(v)3.1 blocker | 0.084 0.05 DBMET01615 0.082 0.053 DBMET01617 | ||
| 0.069 | 0.03 | 0.1 | Calcium channel P-type blocker | 0.071 0.025 DBMET01615 0.064 0.043 DBMET01616 0.1 0.005 DBMET01617 | DBMET01617 | |
| 0.212 | 0.178 | 0.383 | Calpain 2 inhibitor | 0.224 0.168 DBMET01615 0.383 0.07 DBMET01617 | DBMET01617 | |
| 0.156 | 0.124 | 0.168 | Insulin sensitizer | 0.168 0.11 DBMET01615 0.168 0.11 DBMET01617 | DBMET01617 | |
| 0.063 | 0.033 | 0.073 | Protein kinase C theta inhibitor | 0.06 0.037 DBMET01615 0.073 0.019 DBMET01616 | DBMET01616 | |
| 0.093 | 0.063 | 0.131 | Prolactin inhibitor | 0.091 0.066 DBMET01615 0.113 0.044 DBMET01616 0.131 0.031 DBMET01617 | DBMET01617 | |
| 0.064 | 0.034 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.035 DBMET01615 | ||
| 0.087 | 0.058 | 0.095 | Ca(v)2.2 blocker | 0.087 0.058 DBMET01615 0.095 0.052 DBMET01616 | DBMET01616 | |
| 0.1 | 0.072 | 0.103 | 5 Hydroxytryptamine 2 antagonist | 0.103 0.069 DBMET01615 | DBMET01615 | |
| 0.152 | 0.126 | 0.152 | Platelet aggregation inhibitor | 0.15 0.129 DBMET01615 | ||
| 0.037 | 0.011 | 0.039 | Melatonin antagonist | 0.039 0.01 DBMET01615 | DBMET01615 | |
| 0.107 | 0.083 | 0.107 | Acetylcholine muscarinic antagonist | 0.105 0.085 DBMET01615 | ||
| 0.139 | 0.117 | 0.144 | Amyloid beta aggregation inhibitor | 0.144 0.113 DBMET01615 | DBMET01615 | |
| 0.165 | 0.144 | 0.165 | ErbB-1 antagonist | 0.164 0.146 DBMET01615 | ||
| 0.064 | 0.044 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 DBMET01615 | DBMET01615 | |
| 0.036 | 0.018 | 0.047 | Melatonin receptor 1A agonist | 0.039 0.015 DBMET01615 0.047 0.009 DBMET01617 | DBMET01617 | |
| 0.056 | 0.043 | 0.056 | Cathepsin L inhibitor | 0.056 0.043 DBMET01615 0.056 0.042 DBMET01616 | ||
| 0.023 | 0.009 | 0.024 | Melatonin 1 antagonist | 0.024 0.009 DBMET01615 | DBMET01615 | |
| 0.054 | 0.041 | 0.055 | Immunoglobulin Fc receptor antagonist | 0.055 0.038 DBMET01615 0.054 0.043 DBMET01617 | DBMET01615 | |
| 0.049 | 0.037 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 DBMET01615 | DBMET01615 | |
| 0.064 | 0.054 | 0.121 | Protein kinase C alpha inhibitor | 0.061 0.058 DBMET01615 0.121 0.016 DBMET01616 | DBMET01616 | |
| 0.16 | 0.153 | 0.224 | Antioxidant | 0.158 0.155 DBMET01615 0.224 0.099 DBMET01617 | DBMET01617 | |
| 0.076 | 0.069 | 0.077 | Inducible nitric-oxide synthase inhibitor | 0.077 0.068 DBMET01616 | DBMET01616 | |
| 0.121 | 0.114 | 0.157 | Thiol protease inhibitor | 0.129 0.099 DBMET01616 0.157 0.063 DBMET01617 | DBMET01617 | |
| 0.071 | 0.066 | 0.074 | 5 Hydroxytryptamine 2A antagonist | 0.074 0.064 DBMET01615 | DBMET01615 | |
| 0.04 | 0.035 | 0.04 | Cathepsin F inhibitor | 0.039 0.037 DBMET01615 | ||
| 0.253 | 0.25 | 0.527 | Caspase 9 stimulant | 0.26 0.241 DBMET01615 0.351 0.144 DBMET01616 0.527 0.051 DBMET01617 | DBMET01617 | |
| 0.054 | 0.051 | 0.054 | Dopamine D3 antagonist | 0.053 0.052 DBMET01615 | ||
| 0.049 | 0.047 | 0.141 | Beta tubulin antagonist | 0.053 0.044 DBMET01615 0.141 0.013 DBMET01617 | DBMET01617 | |
| 0.111 | 0.111 | 0.159 | Neurotrophic factor | 0.159 0.052 DBMET01617 | DBMET01617 | |
| 0.013 | 0.012 | 0.014 | Melatonin receptor 1A antagonist | 0.014 0.009 DBMET01615 0.014 0.01 DBMET01617 | DBMET01617 | |
| 0.088 | 0.088 | 0.128 | Carbonic anhydrase XV inhibitor | 0.106 0.06 DBMET01616 0.128 0.041 DBMET01617 | DBMET01617 | |
| 0.017 | 0.018 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.015 DBMET01615 | DBMET01615 | |
| 0.049 | 0.051 | 0.083 | Cathepsin B inhibitor | 0.083 0.022 DBMET01617 | DBMET01617 | |
| 0.195 | 0.198 | 0.3 | Interleukin 2 agonist | 0.3 0.074 DBMET01616 | DBMET01616 | |
| 0.151 | 0.154 | 0.21 | Immunostimulant | 0.21 0.114 DBMET01616 0.191 0.126 DBMET01617 | DBMET01616 | |
| 0.03 | 0.037 | 0.033 | Benzodiazepine receptor peripheral-type antagonist | 0.033 0.028 DBMET01616 | DBMET01616 | |
| 0.03 | 0.04 | 0.036 | Cathepsin L1 inhibitor | 0.036 0.031 DBMET01616 | DBMET01616 | |
| 0.033 | 0.045 | 0.046 | Neurokinin 2 agonist | 0.046 0.022 DBMET01616 | DBMET01616 | |
| 0.008 | 0.022 | 0.013 | Melatonin 2 antagonist | 0.013 0.007 DBMET01617 | DBMET01617 | |
| 0.036 | 0.053 | 0.042 | Adenylate cyclase 1 inhibitor | 0.042 0.038 DBMET01617 | DBMET01617 | |
| 0.132 | 0.151 | 0.34 | Succinate dehydrogenase inhibitor | 0.163 0.09 DBMET01616 0.34 0.006 DBMET01617 | DBMET01617 | |
| 0.039 | 0.062 | 0.045 | Benzodiazepine antagonist | 0.045 0.039 DBMET01616 | DBMET01616 | |
| 0.098 | 0.123 | 0.123 | Histone deacetylase SIRT1 inhibitor | 0.123 0.087 DBMET01616 | DBMET01616 | |
| 0.039 | 0.066 | 0.064 | Squalene epoxidase inhibitor | 0.064 0.018 DBMET01616 | DBMET01616 | |
| 0.11 | 0.138 | 0.237 | Growth hormone agonist | 0.237 0.047 DBMET01616 | DBMET01616 | |
| 0.031 | 0.06 | 0.04 | Neurotensin receptor antagonist | 0.04 0.037 DBMET01616 | DBMET01616 | |
| 0.167 | 0.199 | 0.308 | Cholesterol antagonist | 0.209 0.157 DBMET01616 0.308 0.086 DBMET01617 | DBMET01617 | |
| 0.037 | 0.069 | 0.088 | Aminopeptidase microsomal inhibitor | 0.088 0.021 DBMET01617 | DBMET01617 | |
| 0.073 | 0.108 | 0.124 | Expectorant | 0.097 0.072 DBMET01616 0.124 0.048 DBMET01617 | DBMET01617 | |
| 0.112 | 0.149 | 0.127 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.108 DBMET01616 | DBMET01616 | |
| 0.034 | 0.072 | 0.138 | Alpha tubulin antagonist | 0.138 0.011 DBMET01617 | DBMET01617 | |
| 0.096 | 0.135 | 0.119 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.074 DBMET01617 | DBMET01617 | |
| 0.064 | 0.105 | 0.078 | Falcipain inhibitor | 0.078 0.077 DBMET01617 | DBMET01617 | |
| 0.025 | 0.067 | 0.069 | Aminopeptidase N inhibitor | 0.069 0.02 DBMET01617 | DBMET01617 | |
| 0.029 | 0.073 | 0.042 | Vanilloid 3 antagonist | 0.042 0.017 DBMET01617 | DBMET01617 | |
| 0.011 | 0.055 | 0.034 | Sigma 2 receptor antagonist | 0.034 0.015 DBMET01617 | DBMET01617 | |
| 0.11 | 0.155 | 0.203 | Nitric oxide antagonist | 0.203 0.066 DBMET01617 | DBMET01617 | |
| 0.078 | 0.124 | 0.12 | Glutamate (mGluR7) agonist | 0.12 0.03 DBMET01617 | DBMET01617 | |
| 0.016 | 0.062 | 0.025 | Vanilloid 2 agonist | 0.025 0.019 DBMET01617 | DBMET01617 | |
| 0.077 | 0.124 | 0.177 | Proteasome inhibitor | 0.177 0.033 DBMET01617 | DBMET01617 | |
| 0.076 | 0.124 | 0.143 | Mucolytic | 0.094 0.086 DBMET01616 0.143 0.036 DBMET01617 | DBMET01617 | |
| 0.02 | 0.068 | 0.027 | Hedgehog signaling activator | 0.026 0.025 DBMET01616 0.027 0.019 DBMET01617 | DBMET01617 | |
| 0.087 | 0.136 | 0.108 | Sodium channel blocker | 0.108 0.101 DBMET01616 | DBMET01616 | |
| 0.07 | 0.122 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | 0.114 0.041 DBMET01617 | DBMET01617 | |
| 0.018 | 0.07 | 0.081 | Calpain 1 inhibitor | 0.081 0.004 DBMET01617 | DBMET01617 | |
| 0.081 | 0.134 | 0.235 | Factor V inhibitor | 0.235 0.003 DBMET01617 | DBMET01617 | |
| 0.074 | 0.13 | 0.219 | Cholesterol synthesis inhibitor | 0.219 0.023 DBMET01617 | DBMET01617 | |
| 0.062 | 0.121 | 0.101 | Factor XII inhibitor | 0.08 0.066 DBMET01616 0.101 0.037 DBMET01617 | DBMET01617 | |
| 0.025 | 0.084 | 0.077 | Phosphodiesterase 4A inhibitor | 0.077 0.022 DBMET01617 | DBMET01617 | |
| 0.025 | 0.085 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.037 DBMET01617 | DBMET01617 | |
| 0.05 | 0.112 | 0.087 | GABA aminotransferase inhibitor | 0.085 0.04 DBMET01616 0.087 0.038 DBMET01617 | DBMET01617 | |
| 0.107 | 0.172 | 0.163 | Interferon gamma antagonist | 0.163 0.063 DBMET01617 | DBMET01617 | |
| 0.096 | 0.161 | 0.124 | Sigma receptor agonist | 0.124 0.109 DBMET01617 | DBMET01617 | |
| 0.02 | 0.089 | 0.055 | Dopamine D5 agonist | 0.055 0.014 DBMET01617 | DBMET01617 | |
| 0.031 | 0.11 | 0.067 | TRPA1 antagonist | 0.067 0.035 DBMET01617 | DBMET01617 | |
| 0.054 | 0.141 | 0.087 | Protease inhibitor | 0.087 0.077 DBMET01617 | DBMET01617 | |
| 0.049 | 0.139 | 0.127 | Aminopeptidase B inhibitor | 0.098 0.067 DBMET01616 0.127 0.049 DBMET01617 | DBMET01617 | |
| 0.027 | 0.118 | 0.088 | Purinergic P2X2 antagonist | 0.088 0.036 DBMET01617 | DBMET01617 | |
| 0.061 | 0.155 | 0.14 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.075 DBMET01616 0.14 0.007 DBMET01617 | DBMET01617 | |
| 0.1 | 0.195 | 0.289 | Tumour necrosis factor antagonist | 0.146 0.106 DBMET01616 0.289 0.02 DBMET01617 | DBMET01617 | |
| 0.081 | 0.177 | 0.164 | Protein kinase stimulant | 0.164 0.059 DBMET01616 0.129 0.084 DBMET01617 | DBMET01616 | |
| 0.042 | 0.138 | 0.07 | Ryanodine receptor antagonist | 0.07 0.018 DBMET01617 | DBMET01617 | |
| 0.084 | 0.186 | 0.168 | Psychostimulant | 0.168 0.101 DBMET01617 | DBMET01617 | |
| 0.034 | 0.137 | 0.106 | Phosphodiesterase 4D inhibitor | 0.106 0.034 DBMET01617 | DBMET01617 | |
| 0.135 | 0.238 | 0.229 | Transcription factor STAT3 inhibitor | 0.189 0.149 DBMET01616 0.229 0.102 DBMET01617 | DBMET01617 | |
| 0.046 | 0.153 | 0.092 | Carbonic anhydrase VI inhibitor | 0.092 0.045 DBMET01617 | DBMET01617 | |
| 0.026 | 0.134 | 0.059 | 5 Hydroxytryptamine 2A agonist | 0.059 0.048 DBMET01617 | DBMET01617 | |
| 0.038 | 0.146 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | 0.091 0.02 DBMET01617 | DBMET01617 | |
| 0.068 | 0.178 | 0.11 | Sodium channel (voltage-gated) blocker | 0.11 0.097 DBMET01616 | DBMET01616 | |
| 0.011 | 0.123 | 0.032 | Phosphoglycerate kinase inhibitor | 0.032 0.029 DBMET01617 | DBMET01617 | |
| 0.035 | 0.15 | 0.096 | Cathepsin G inhibitor | 0.096 0.035 DBMET01617 | DBMET01617 | |
| 0.115 | 0.233 | 0.14 | Heat shock protein 70 antagonist | 0.133 0.105 DBMET01616 0.14 0.075 DBMET01617 | DBMET01617 | |
| 0.029 | 0.147 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.061 0.022 DBMET01617 | DBMET01617 | |
| 0.03 | 0.15 | 0.082 | Amidase inhibitor | 0.082 0.036 DBMET01617 | DBMET01617 | |
| 0.119 | 0.239 | 0.242 | 5 Hydroxytryptamine 1E antagonist | 0.242 0.083 DBMET01617 | DBMET01617 | |
| 0.04 | 0.16 | 0.092 | Somatostatin 1 agonist | 0.092 0.04 DBMET01616 | DBMET01616 | |
| 0.022 | 0.145 | 0.061 | Prolyl endopeptidase inhibitor | 0.061 0.023 DBMET01617 | DBMET01617 | |
| 0.055 | 0.181 | 0.103 | Carbonic anhydrase III inhibitor | 0.103 0.059 DBMET01617 | DBMET01617 | |
| 0.028 | 0.154 | 0.077 | Lipase inhibitor | 0.077 0.046 DBMET01617 | DBMET01617 | |
| 0.042 | 0.171 | 0.093 | Exportin-1 inhibitor | 0.093 0.013 DBMET01617 | DBMET01617 | |
| 0.05 | 0.179 | 0.092 | GABA B receptor agonist | 0.092 0.023 DBMET01616 0.092 0.024 DBMET01617 | DBMET01617 | |
| 0.023 | 0.157 | 0.065 | Alpha-mannosidase inhibitor | 0.065 0.021 DBMET01617 | DBMET01617 | |
| 0.063 | 0.199 | 0.165 | DOPA decarboxylase inhibitor | 0.165 0.015 DBMET01617 | DBMET01617 | |
| 0.06 | 0.195 | 0.159 | 3C-Like protease (SARS coronavirus) inhibitor | 0.159 0.008 DBMET01617 | DBMET01617 | |
| 0.076 | 0.212 | 0.231 | Phospholipase A2 inhibitor | 0.231 0.029 DBMET01617 | DBMET01617 | |
| 0.086 | 0.223 | 0.131 | Hemostatic | 0.131 0.095 DBMET01616 | DBMET01616 | |
| 0.1 | 0.239 | 0.251 | Neurotrophic factor enhancer | 0.251 0.038 DBMET01617 | DBMET01617 | |
| 0.02 | 0.16 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.03 DBMET01617 | DBMET01617 | |
| 0.121 | 0.261 | 0.239 | 12-Lipoxygenase inhibitor | 0.239 0.116 DBMET01617 | DBMET01617 | |
| 0.025 | 0.17 | 0.065 | Carbonic anhydrase VA inhibitor | 0.065 0.053 DBMET01617 | DBMET01617 | |
| 0.145 | 0.291 | 0.44 | Caspase 3 stimulant | 0.44 0.032 DBMET01617 | DBMET01617 | |
| 0.112 | 0.26 | 0.179 | Lipoxygenase inhibitor | 0.179 0.165 DBMET01617 | DBMET01617 | |
| 0.142 | 0.293 | 0.311 | Apoptosis antagonist | 0.311 0.078 DBMET01617 | DBMET01617 | |
| 0.048 | 0.201 | 0.102 | Anabolic | 0.102 0.059 DBMET01617 | DBMET01617 | |
| 0.041 | 0.194 | 0.09 | Keratolytic | 0.09 0.037 DBMET01617 | DBMET01617 | |
| 0.056 | 0.21 | 0.112 | Nav1.4 sodium channel blocker | 0.112 0.06 DBMET01616 | DBMET01616 | |
| 0.024 | 0.184 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.031 DBMET01617 | DBMET01617 | |
| 0.064 | 0.225 | 0.156 | Angiogenesis stimulant | 0.156 0.119 DBMET01616 | DBMET01616 | |
| 0.041 | 0.202 | 0.068 | Transcription factor RelA inhibitor | 0.068 0.033 DBMET01617 | DBMET01617 | |
| 0.055 | 0.219 | 0.134 | Thrombolytic | 0.134 0.095 DBMET01616 | DBMET01616 | |
| 0.036 | 0.2 | 0.072 | Caspase 9 inhibitor | 0.072 0.03 DBMET01617 | DBMET01617 | |
| 0.032 | 0.197 | 0.134 | Monophenol monooxygenase inhibitor | 0.134 0.054 DBMET01617 | DBMET01617 | |
| 0.056 | 0.222 | 0.154 | Microtubule formation inhibitor | 0.154 0.036 DBMET01617 | DBMET01617 | |
| 0.059 | 0.228 | 0.134 | Photosensitizer | 0.134 0.043 DBMET01617 | DBMET01617 | |
| 0.013 | 0.183 | 0.071 | Aromatase inhibitor | 0.071 0.034 DBMET01617 | DBMET01617 | |
| 0.051 | 0.224 | 0.107 | ABCA1 expression enhancer | 0.107 0.041 DBMET01617 | DBMET01617 | |
| 0.017 | 0.195 | 0.075 | Argininosuccinate synthase inhibitor | 0.075 0.028 DBMET01617 | DBMET01617 | |
| 0.05 | 0.23 | 0.124 | Caspase 3 inhibitor | 0.124 0.054 DBMET01617 | DBMET01617 | |
| 0.001 | 0.186 | 0.027 | Antibiotic Macrolide-like | 0.027 0.005 DBMET01617 | DBMET01617 | |
| 0.039 | 0.225 | 0.097 | Caspase 7 inhibitor | 0.097 0.032 DBMET01617 | DBMET01617 | |
| 0.013 | 0.202 | 0.052 | Mannosidase inhibitor | 0.052 0.023 DBMET01617 | DBMET01617 | |
| 0.06 | 0.249 | 0.22 | Interleukin 4 antagonist | 0.22 0.018 DBMET01617 | DBMET01617 | |
| 0.074 | 0.264 | 0.145 | Hepatoprotectant | 0.145 0.115 DBMET01617 | DBMET01617 | |
| 0.024 | 0.216 | 0.093 | Phosphodiesterase IV inhibitor | 0.093 0.05 DBMET01617 | DBMET01617 | |
| 0.007 | 0.201 | 0.034 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET01617 | DBMET01617 | |
| 0.038 | 0.234 | 0.079 | Chymotrypsin inhibitor | 0.079 0.056 DBMET01617 | DBMET01617 | |
| 0.016 | 0.225 | 0.214 | Protein 50S ribosomal subunit inhibitor | 0.214 0.004 DBMET01617 | DBMET01617 | |
| 0.019 | 0.228 | 0.166 | Catalase inhibitor | 0.166 0.023 DBMET01617 | DBMET01617 | |
| 0.066 | 0.276 | 0.179 | Anticonvulsant | 0.179 0.1 DBMET01616 | DBMET01616 | |
| 0.053 | 0.266 | 0.363 | Aldehyde dehydrogenase inhibitor | 0.105 0.089 DBMET01616 0.363 0.007 DBMET01617 | DBMET01617 | |
| 0.014 | 0.228 | 0.051 | Dihydrofolate reductase inhibitor | 0.051 0.017 DBMET01617 | DBMET01617 | |
| 0.023 | 0.238 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.04 DBMET01617 | DBMET01617 | |
| 0.075 | 0.291 | 0.24 | Non-steroidal antiinflammatory agent | 0.24 0.047 DBMET01617 | DBMET01617 | |
| 0.023 | 0.24 | 0.188 | Carbonic anhydrase XIII inhibitor | 0.188 0.016 DBMET01617 | DBMET01617 | |
| 0.027 | 0.247 | 0.07 | Pregnane X receptor antagonist | 0.07 0.015 DBMET01617 | DBMET01617 | |
| 0.003 | 0.224 | 0.014 | 3C-Like protease (MERS coronavirus) inhibitor | 0.014 0.005 DBMET01617 | DBMET01617 | |
| 0.065 | 0.288 | 0.139 | Antimitotic | 0.139 0.133 DBMET01616 | DBMET01616 | |
| 0.105 | 0.328 | 0.187 | Transcription factor STAT inhibitor | 0.187 0.157 DBMET01617 | DBMET01617 | |
| 0.016 | 0.24 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.049 DBMET01617 | DBMET01617 | |
| 0.051 | 0.275 | 0.084 | Toll-Like receptor 3 antagonist | 0.084 0.083 DBMET01616 | DBMET01616 | |
| 0.06 | 0.286 | 0.187 | Arachidonic acid antagonist | 0.187 0.046 DBMET01617 | DBMET01617 | |
| 0.007 | 0.233 | 0.04 | Oleamide hydrolase inhibitor | 0.04 0.037 DBMET01617 | DBMET01617 | |
| 0.02 | 0.253 | 0.163 | Glutamate decarboxylase inhibitor | 0.163 0.011 DBMET01617 | DBMET01617 | |
| 0.054 | 0.291 | 0.218 | Peroxidase inhibitor | 0.218 0.054 DBMET01617 | DBMET01617 | |
| 0.033 | 0.273 | 0.083 | Glycine receptor agonist | 0.083 0.035 DBMET01616 0.068 0.059 DBMET01617 | DBMET01616 | |
| 0.018 | 0.258 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.043 DBMET01617 | DBMET01617 | |
| 0.062 | 0.305 | 0.194 | Interleukin agonist | 0.184 0.136 DBMET01616 0.194 0.126 DBMET01617 | DBMET01617 | |
| 0.124 | 0.369 | 0.199 | 5 Hydroxytryptamine 3E antagonist | 0.199 0.064 DBMET01617 | DBMET01617 | |
| 0.152 | 0.401 | 0.423 | 5 Hydroxytryptamine release inhibitor | 0.423 0.065 DBMET01617 | DBMET01617 | |
| 0.016 | 0.265 | 0.039 | Glutamate (mGluR8) agonist | 0.039 0.024 DBMET01617 | DBMET01617 | |
| 0.022 | 0.273 | 0.071 | Elastase 1 inhibitor | 0.071 0.046 DBMET01617 | DBMET01617 | |
| 0.064 | 0.322 | 0.167 | GABA C receptor rho-2 antagonist | 0.167 0.053 DBMET01617 | DBMET01617 | |
| 0.026 | 0.285 | 0.089 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 DBMET01617 | DBMET01617 | |
| 0.017 | 0.278 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.025 DBMET01617 | DBMET01617 | |
| 0.032 | 0.3 | 0.123 | GABA C receptor agonist | 0.092 0.076 DBMET01616 0.123 0.048 DBMET01617 | DBMET01617 | |
| 0.02 | 0.288 | 0.057 | Heparanase inhibitor | 0.057 0.029 DBMET01617 | DBMET01617 | |
| 0.129 | 0.401 | 0.255 | Apoptosis agonist | 0.255 0.208 DBMET01617 | DBMET01617 | |
| 0.087 | 0.359 | 0.267 | Hypoxia-inducible factor 1 alpha inhibitor | 0.267 0.086 DBMET01617 | DBMET01617 | |
| 0.019 | 0.293 | 0.068 | CYP2A6 inhibitor | 0.068 0.062 DBMET01617 | DBMET01617 | |
| 0.016 | 0.293 | 0.033 | Adenosine uptake inhibitor | 0.033 0.031 DBMET01617 | DBMET01617 | |
| 0.009 | 0.287 | 0.036 | GABA uptake inhibitor | 0.036 0.032 DBMET01617 | DBMET01617 | |
| 0.016 | 0.296 | 0.116 | Histidine decarboxylase inhibitor | 0.116 0.027 DBMET01617 | DBMET01617 | |
| 0.056 | 0.336 | 0.166 | DNA methyltransferase I inhibitor | 0.166 0.089 DBMET01617 | DBMET01617 | |
| 0.141 | 0.422 | 0.309 | Calcium channel L-type activator | 0.309 0.15 DBMET01617 | DBMET01617 | |
| 0.015 | 0.299 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.046 DBMET01617 | DBMET01617 | |
| 0.051 | 0.338 | 0.171 | Interleukin antagonist | 0.171 0.103 DBMET01616 | DBMET01616 | |
| 0.031 | 0.318 | 0.106 | GABA C receptor antagonist | 0.106 0.069 DBMET01616 | DBMET01616 | |
| 0.039 | 0.329 | 0.14 | Interleukin 1b antagonist | 0.14 0.047 DBMET01617 | DBMET01617 | |
| 0.029 | 0.322 | 0.189 | Cystathionine beta-synthase inhibitor | 0.189 0.027 DBMET01617 | DBMET01617 | |
| 0.014 | 0.308 | 0.04 | AICAR transformylase inhibitor | 0.04 0.038 DBMET01617 | DBMET01617 | |
| 0.057 | 0.352 | 0.173 | DNA methylase inhibitor | 0.173 0.098 DBMET01617 | DBMET01617 | |
| 0.011 | 0.32 | 0.118 | Phosphofructokinase-1 inhibitor | 0.118 0.026 DBMET01617 | DBMET01617 | |
| 0.032 | 0.344 | 0.094 | GABA C receptor rho-1 antagonist | 0.094 0.072 DBMET01617 | DBMET01617 | |
| 0.005 | 0.317 | 0.055 | Kinesin antagonist | 0.055 0.015 DBMET01616 | DBMET01616 | |
| 0.005 | 0.317 | 0.055 | Kinesin-like protein 1 inhibitor | 0.055 0.015 DBMET01616 | DBMET01616 | |
| 0.016 | 0.329 | 0.074 | Cyclin D1 inhibitor | 0.074 0.023 DBMET01617 | DBMET01617 | |
| 0.084 | 0.397 | 0.204 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.204 0.069 DBMET01617 | DBMET01617 | |
| 0.038 | 0.366 | 0.1 | Thioredoxin reductase inhibitor | 0.1 0.028 DBMET01617 | DBMET01617 | |
| 0.023 | 0.359 | 0.109 | Alkylator | 0.109 0.079 DBMET01617 | DBMET01617 | |
| 0.052 | 0.392 | 0.175 | Interleukin 6 antagonist | 0.175 0.059 DBMET01617 | DBMET01617 | |
| 0.033 | 0.373 | 0.306 | Amylase inhibitor | 0.306 0.017 DBMET01617 | DBMET01617 | |
| 0.031 | 0.375 | 0.106 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.106 0.049 DBMET01617 | DBMET01617 | |
| 0.036 | 0.384 | 0.136 | Interleukin 5 antagonist | 0.136 0.015 DBMET01617 | DBMET01617 | |
| 0.005 | 0.361 | 0.038 | Guanylate cyclase inhibitor | 0.038 0.036 DBMET01617 | DBMET01617 | |
| 0.012 | 0.37 | 0.05 | Aconitate hydratase inhibitor | 0.05 0.039 DBMET01617 | DBMET01617 | |
| 0.014 | 0.374 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.091 0.042 DBMET01617 | DBMET01617 | |
| 0.032 | 0.395 | 0.087 | NADH dehydrogenase inhibitor | 0.087 0.062 DBMET01617 | DBMET01617 | |
| 0.042 | 0.405 | 0.176 | Amyloid beta precursor protein antagonist | 0.176 0.076 DBMET01617 | DBMET01617 | |
| 0.021 | 0.39 | 0.041 | Heme oxygenase inhibitor | 0.041 0.037 DBMET01617 | DBMET01617 | |
| 0.012 | 0.391 | 0.067 | Phenylalanine 4-hydroxylase inhibitor | 0.067 0.049 DBMET01617 | DBMET01617 | |
| 0.087 | 0.468 | 0.257 | GABA C receptor rho-3 antagonist | 0.257 0.148 DBMET01617 | DBMET01617 | |
| 0.087 | 0.47 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.054 DBMET01617 | DBMET01617 | |
| 0.008 | 0.394 | 0.158 | Alcohol oxidase inhibitor | 0.158 0.009 DBMET01617 | DBMET01617 | |
| 0.02 | 0.407 | 0.106 | DNA intercalator | 0.106 0.067 DBMET01617 | DBMET01617 | |
| 0.035 | 0.424 | 0.23 | NADPH oxidase inhibitor | 0.23 0.025 DBMET01617 | DBMET01617 | |
| 0.014 | 0.407 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.066 0.014 DBMET01617 | DBMET01617 | |
| 0.04 | 0.435 | 0.132 | Adenylate kinase inhibitor | 0.132 0.035 DBMET01617 | DBMET01617 | |
| 0.018 | 0.415 | 0.096 | Urease inhibitor | 0.096 0.072 DBMET01617 | DBMET01617 | |
| 0.009 | 0.409 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | 0.077 0.053 DBMET01617 | DBMET01617 | |
| 0.016 | 0.42 | 0.095 | Glutamate (mGluR7) antagonist | 0.095 0.013 DBMET01617 | DBMET01617 | |
| 0.051 | 0.459 | 0.194 | ATPase inhibitor | 0.194 0.042 DBMET01617 | DBMET01617 | |
| 0.007 | 0.418 | 0.049 | Xanthine dehydrogenase inhibitor | 0.049 0.047 DBMET01617 | DBMET01617 | |
| 0.025 | 0.442 | 0.096 | HIV-1 integrase (Overall Integration) inhibitor | 0.096 0.058 DBMET01617 | DBMET01617 | |
| 0.051 | 0.468 | 0.165 | CF transmembrane conductance regulator agonist | 0.165 0.053 DBMET01617 | DBMET01617 | |
| 0.067 | 0.489 | 0.262 | Histamine release inhibitor | 0.262 0.147 DBMET01617 | DBMET01617 | |
| 0.025 | 0.449 | 0.3 | Alpha-N-acetylglucosaminidase inhibitor | 0.3 0.016 DBMET01617 | DBMET01617 | |
| 0.047 | 0.473 | 0.219 | DNA synthesis inhibitor | 0.219 0.096 DBMET01617 | DBMET01617 | |
| 0.026 | 0.456 | 0.153 | Triose-phosphate isomerase inhibitor | 0.153 0.019 DBMET01617 | DBMET01617 | |
| 0.098 | 0.536 | 0.534 | Antiinflammatory | 0.534 0.074 DBMET01617 | DBMET01617 | |
| 0.007 | 0.463 | 0.059 | Acetylcholine M5 receptor agonist | 0.059 0.056 DBMET01617 | DBMET01617 | |
| 0.009 | 0.472 | 0.065 | Porphobilinogen synthase inhibitor | 0.065 0.061 DBMET01617 | DBMET01617 | |
| 0.018 | 0.493 | 0.19 | UDP-glucose 4-epimerase inhibitor | 0.19 0.019 DBMET01617 | DBMET01617 | |
| 0.04 | 0.517 | 0.164 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.13 DBMET01617 | DBMET01617 | |
| 0.039 | 0.529 | 0.286 | 3C-like protease (Human coronavirus) inhibitor | 0.286 0.015 DBMET01617 | DBMET01617 | |
| 0.023 | 0.518 | 0.15 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.15 0.143 DBMET01617 | DBMET01617 | |
| 0.011 | 0.507 | 0.102 | Alcohol dehydrogenase inhibitor | 0.102 0.051 DBMET01617 | DBMET01617 | |
| 0.109 | 0.628 | 0.34 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.34 0.163 DBMET01617 | DBMET01617 | |
| 0.054 | 0.574 | 0.152 | Death-associated protein kinase 2 inhibitor | 0.152 0.102 DBMET01616 | DBMET01616 | |
| 0.015 | 0.545 | 0.072 | Purinergic P2X1 antagonist | 0.072 0.031 DBMET01617 | DBMET01617 | |
| 0.032 | 0.589 | 0.17 | Hexokinase inhibitor | 0.17 0.058 DBMET01617 | DBMET01617 | |
| 0.045 | 0.612 | 0.194 | RNA-directed DNA polymerase inhibitor | 0.194 0.109 DBMET01617 | DBMET01617 | |
| 0.017 | 0.587 | 0.228 | Mannose-6-phosphate isomerase inhibitor | 0.228 0.018 DBMET01617 | DBMET01617 | |
| 0.037 | 0.612 | 0.278 | Antibacterial | 0.278 0.153 DBMET01617 | DBMET01617 | |
| 0.014 | 0.61 | 0.112 | Beta glucuronidase inhibitor | 0.112 0.054 DBMET01617 | DBMET01617 | |
| 0.005 | 0.638 | 0.06 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.035 DBMET01617 | DBMET01617 | |
| 0.01 | 0.649 | 0.187 | Pyruvate kinase inhibitor | 0.187 0.089 DBMET01617 | DBMET01617 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |